Parp Inhibitors Therapy for Metastatic Prostate Cancer
No contributors found.
Release Date: 2024-06-19
In this section, the success of targeted therapies that have proven effective in the last 20 years in metastatic prostate cancer is highlighted. Prostate cancer is one of the three most common cancers among men worldwide, and new treatment options are still being investigated. PARP (polyadenosine diphospate ribose polymerase) inhibitors might contribute clinical benefit in [...]
